Rani Therapeutics Holdings (RANI) Return on Sales (2020 - 2026)
Rani Therapeutics Holdings (RANI) posted quarterly Return on Sales of 0.06% for Q1 2026, up 68.0% year-over-year from 0.04% in Q1 2025, and down 2.66% quarter-over-quarter from 0.06% in Q4 2025.
Rani Therapeutics Holdings (RANI) Return on Sales (2020 - 2026) Analysis & Trends
Rani Therapeutics Holdings' Return on Sales history runs 6 years deep, the most recent figure standing at 0.06% for Q1 2026.
- In Q1 2026, Return on Sales rose 68.0% year-over-year to 0.06%; the TTM figure through Mar 2026 stood at 0.13% (up 34.0% YoY), while the FY2025 annual figure was 0.71%, down 16.0% from the prior year.
- Return on Sales for Q1 2026 stood at 0.06%, down from 0.06% in the prior quarter.
- The five-year high for Return on Sales was 0.06% in Q4 2025, with the low at 0.74% in Q1 2025.
- The 4-year median for Return on Sales is 0.37% (2022), against an average of 0.31%.
- The sharpest annual moves came in 2022 and 2026: Return on Sales sank 34 bps in 2022, then surged 68 bps in 2026.
- Rani Therapeutics Holdings' Return on Sales stood at 0.37% in 2022, then jumped by 68 bps to 0.12% in 2024, then surged by 50 bps to 0.06% in 2025, then declined by 3 bps to 0.06% in 2026.
- Business Quant data shows RANI's Return on Sales at 0.06% in Q1 2026, 0.06% in Q4 2025, and 0.4% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.50 Bn | 131.65 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.10 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 65.59 Bn | 60.41 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 56.75 Bn | 51.62 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 42.11 Bn | 37.01 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.64 Bn | 28.33 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 27.80 Bn | 9.41 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | 0.00% |
| 10 | Rani Therapeutics Holdings | 165.19 Mn | 165.19 Mn | - | -0.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.07% |
| Mar 31, 2026 | -0.06% |
| Dec 31, 2025 | -0.06% |
| Sep 30, 2025 | -0.40% |
| Jun 30, 2025 | -0.45% |
| Mar 31, 2025 | -0.74% |
| Dec 31, 2024 | -0.12% |
| Jun 30, 2022 | -0.37% |
| Dec 31, 2021 | -0.20% |
| Sep 30, 2021 | -0.16% |
| Jun 30, 2021 | -0.03% |
| Mar 31, 2021 | -0.07% |
| Dec 31, 2020 | -0.27% |
| Sep 30, 2020 | -0.27% |
| Jun 30, 2020 | -0.45% |